Skip to main content
British Journal of Clinical Pharmacology logoLink to British Journal of Clinical Pharmacology
. 1980 Apr;9(4):327–331. doi: 10.1111/j.1365-2125.1980.tb01058.x

Induction of delta-aminolaevulinic acid synthase in leucocytes of patients on phenytoin therapy--comparison with changes in rat hepatic tissue.

K E McColl, M R Moore, G G Thompson, A Goldberg
PMCID: PMC1429979  PMID: 7378249

Abstract

1 In rats daily phenytoin (DPH) administration resulted in an increase in hepatic cytochrome P450 content. The rise in cytochrome P450 was associated with a temporary increase in the acitvity of hepatic delta-aminolaevulinic acid (ALA) synthase. 2 In patients newly commenced on DPH anticonvulsant therapy the activity of ALA synthase in peripheral leucocytes showed a marked temporary increase during the first 10 days of therapy. 3 These findings suggest that DPH induces a haem-requiring eenzyme system in peripheral leucocytes as well as in hepatic tissue.

Full text

PDF
327

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Bhat K. S., Sardana M. K., Padmanaban G. Role of haem in the synthesis and assembly of cytochrome P-450. Biochem J. 1977 May 15;164(2):295–303. doi: 10.1042/bj1640295. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Bonkowsky H. L., Pomeroy J. S. Human hepatic delta-aminolaevulinate synthase: requirement of an exogenous system for succinyl-coenzyme A generation to demonstrate increased activity in cirrhotic and anticonvulsant-treated subjects. Clin Sci Mol Med. 1977 May;52(5):509–521. doi: 10.1042/cs0520509. [DOI] [PubMed] [Google Scholar]
  3. Brodie M. J., Thompson G. G., Moore M. R., Beattie A. D., Goldberg A. Hereditary coproporphyria. Demonstration of the abnormalities in haem biosynthesis in peripheral blood. Q J Med. 1977 Apr;46(182):229–241. [PubMed] [Google Scholar]
  4. De Matteis F., Gibbs A. Stimulation of liver 5-aminolaevulinate synthetase by drugs and its relevance to drug-induced accumulation of cytochrome P-450. Studies with phenylbutazone and 3,5-diethoxycarbonyl-1,4-dihydrocollidine. Biochem J. 1972 Mar;126(5):1149–1160. doi: 10.1042/bj1261149. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Martelli M. F., Aversa F., Rambotti P., Velardi A. Trimethoprim-induced elevation of dihydrofolate reductase activity in human leukocytes. Enzyme. 1978;23(3):154–163. doi: 10.1159/000458570. [DOI] [PubMed] [Google Scholar]
  6. Meyer U. A. Drug sensitivity in hereditary hepatic porphyria. Hum Genet Suppl. 1978;(1):71–78. doi: 10.1007/978-3-642-67179-1_11. [DOI] [PubMed] [Google Scholar]
  7. OMURA T., SATO R. THE CARBON MONOXIDE-BINDING PIGMENT OF LIVER MICROSOMES. I. EVIDENCE FOR ITS HEMOPROTEIN NATURE. J Biol Chem. 1964 Jul;239:2370–2378. [PubMed] [Google Scholar]
  8. Padmanaban G., Rao M. R., Malathi K. A model for the regulation of delta-aminolaevulinate synthetase induction in rat liver. Biochem J. 1973 Aug;134(4):847–857. doi: 10.1042/bj1340847. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. Parikh R. K., Moore M. R. Effect of certain anaesthetic agents on the activity of rat hepatic delta-aminolaevulinate synthase. Br J Anaesth. 1978 Nov;50(11):1099–1103. doi: 10.1093/bja/50.11.1099. [DOI] [PubMed] [Google Scholar]
  10. Rajamanickam C., Rao M. R., Padmanaban G. On the sequence of reactions leading to cytochrome P-450 synthesis-effect of drugs. J Biol Chem. 1975 Mar 25;250(6):2305–2310. [PubMed] [Google Scholar]
  11. Rifkind A. B., Gillette P. N., Song C. S., Kappas A. Drug stimulation of -aminolevulinic acid synthetase and cytochrome P-450 in vivo in chick embryo liver. J Pharmacol Exp Ther. 1973 May;185(2):214–225. [PubMed] [Google Scholar]

Articles from British Journal of Clinical Pharmacology are provided here courtesy of British Pharmacological Society

RESOURCES